The global incidence of urolithiasis has doubled over the past four decades, potentially exacerbated by climate change. Fetuin-A (alpha-2-Heremans-Schmid glycoprotein) is a novel biomarker known for inhibiting calcification and is linked to chronic kidney disease and metabolic syndrome. This study aims to evaluate the association between fetuin-A levels and urolithiasis.
Methods:
A systematic search of MEDLINE, ScienceDirect, ProQuest, EBSCO, Google Scholar, and Cochrane Library was conducted for case-control studies comparing fetuin-A levels in urolithiasis patients versus controls. Study quality was assessed using the JBI Critical Appraisal tool. Meta-analysis was performed with RevMan and JASP.
Results:
Seven case-control studies comprising 395 urolithiasis patients and 282 controls (total n = 677) were included. Urinary fetuin-A levels were significantly lower in urolithiasis patients (SMD = -2.24, 95% CI: -4.24 to -0.23, p = 0.029, I² = 98%). Six studies also reported a trend of reduced serum fetuin-A levels.
Conclusions:
Fetuin-A may serve as a potential predictive biomarker for urolithiasis, particularly in recurrent cases. Significant urinary differences and serum trends warrant further research to clarify its diagnostic and prognostic value.
ZhuCWangDQZiH, et alEpidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Military Med Res2021; 8(1): 64.
2.
QianXWanJXuJ, et alEpidemiological trends of urolithiasis at the global, regional, and national levels: A population-based study. Int J Clin Pract2022; 2022: 6807203.
3.
LiuYChenYLiaoB, et alEpidemiology of urolithiasis in Asia. Asian J Urol2018; 5(4): 205–214.
4.
AbufarajMAl KarmiJYangL.Prevalence and trends of urolithiasis among adults. Curr Opin Urol2022; 32(4): 425–432.
5.
ParkJMEunSJNaYG.Development and evaluation of urolithiasis detection technology based on a multimethod algorithm. Int Neurourol J2023; 27(1): 70–76.
6.
AndrabiYPatinoMDasCJ, et alAdvances in CT imaging for urolithiasis. Indian J Urol2015; 31(3): 185–193.
7.
LasotaAWasilewskaARybi-SzumińskaA.Current status of protein biomarkers in urolithiasis – a review of the recent literature. J Clin Med2023; 12(22): 7135.
8.
ChatterjeePSealSMukherjeeS, et alAdipocyte fetuin-A contributes to macrophage migration into adipose tissue and polarization of macrophages. J Biol Chem2013; 288(39): 28324–28330.
9.
Chekol AbebeETilahun MucheZBehaile T/MariamA, et alThe structure, biosynthesis, and biological roles of fetuin-A: A review. Front Cell Dev Biol2022; 10: 945287.
10.
CaglarKYilmazMISaglamM, et alShort-term treatment with sevelamer increases serum fetuin-A concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol2008; 3(1): 61–68.
11.
ZhouHPisitkunTAponteA, et alExosomal Fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int2006; 70(10): 1847–1857.
12.
PageMJMcKenzieJEBossuytPM, et alThe PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med2021; 18(3): e1003583.
13.
MunnZBarkerTHMoolaS, et alMethodological quality of case series studies: An introduction to the JBI critical appraisal tool. JBI Evid Synth2020; 18(10): 2127–2133.
14.
HigginsJPTThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med2002; 21(11): 1539–1558.
15.
BowdenJDavey SmithGBurgessS.Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J Epidemiol2015; 44(2): 512–525.
16.
StejskalDKarpisekMVrtalR, et alUrine fetuin-A values in relation to the presence of urolithiasis. BJU Int2008; 101(9): 1151–1154.
17.
AksoyHAksoyYOzturkN, et alFetuin-A gene polymorphism in patients with calcium oxalate stone disease. Urology2010; 75(4): 928–932.
18.
GurbuzCPolatHYildirimA, et alThe role of alpha2-heremans schmid glycoprotein (Fetuin-A) in the etiology of urolithiasis. Curr Urol2010; 4(1): 10–14.
19.
PreziosoDSaitaAMottaM, et alSerum fetuin-A and recurrent urolithiasis in young adults. Arch Ital Urol Androl2013; 85(4): 180–183.
20.
WuYXLiCYDengYL.Patients with nephrolithiasis had lower fetuin-A protein level in urine and renal tissue. Urolithiasis2014; 42(1): 29–37.
21.
AroraRAbrolNAntonisamyB, et alUrine and serum fetuin-A levels in patients with urolithiasis. Indian J Urol2017; 33(4): 291–293.
22.
MehrsaiAGuitynavardFNikoobakhtMR, et alThe relationship between serum and urinary fetuin-A levels and kidney stone formation among kidney stone patients. Cent European J Urol2017; 70(4): 394–399.
23.
PedersenKO.Fetuin, a new globulin isolated from serum. Nature1944; 154(3914): 575–575.
24.
BourebabaLMaryczK.Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: A concise review. J Clin Med2019; 8(12): 2033.
25.
PanXWenSWBestmanPL, et alFetuin-A in metabolic syndrome: A systematic review and meta-analysis. PLoS ONE2020; 15(3): e0229776.
26.
GuoVYCaoBCaiC, et alFetuin-A levels and risk of type 2 diabetes mellitus: A systematic review and meta-analysis. Acta Diabetol2018; 55(1): 87–98.
27.
Ramírez-VélezRGarcía-HermosoAHackneyAC, et alEffects of exercise training on Fetuin-a in obese, type 2 diabetes and cardiovascular disease in adults and elderly: A systematic review and Meta-analysis. Lipids Health Dis2019; 18: 23.
28.
WeikertCStefanNSchulzeMB, et alPlasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation2008; 118(24): 2555–2562.
29.
Jahnen-DechentWHeissASchäferC, et alFetuin-A regulation of calcified matrix metabolism. Circ Res2011; 108(12): 1494–1509.
30.
IsmailNARagabSEl DayemSMA, et alFetuin-A levels in obesity: Differences in relation to metabolic syndrome and correlation with clinical and laboratory variables. Arch Med Sci2012; 8(5): 826–833.
31.
ShimYSKangMJOhYJ, et alFetuin-A as an alternative marker for insulin resistance and cardiovascular risk in prepubertal children. J Atheroscler Thromb2017; 24(10): 1031–1038.
32.
AkramRSIsaaMQMohammedAA.Fetuin-A levels and insulin resistance in obese and non-obese Iraqi children. J Popl Ther Clin Pharmacol2023; 30(6): 414–420.
33.
WiggerMSchaibleJMuscheitesJ, et alFetuin-A serum concentrations in healthy children. Ann Clin Biochem2009; 46(pt 6): 511–513.
34.
JenkinsNTMcKenzieJAHagbergJM, et alPlasma fetuin-A concentrations in young and older high- and low-active men. Metabolism2011; 60(2): 265–271.
35.
DabrowskaAMTarachJSWojtysiak-DumaB, et alFetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub2015; 159(3): 352–359.
36.
PhamTMCarpenterJRMorrisTP, et alEthnic differences in the prevalence of type 2 diabetes diagnoses in the UK: Cross-sectional analysis of the health improvement network primary care database. Clin Epidemiol2019; 11: 1081–1088.
37.
JanevicTMcCarthyKLiuSH, et alRacial and ethnic inequities in development of type 2 diabetes after gestational diabetes mellitus. Obstet Gynecol2023; 142(4): 901–910.
38.
SyoufiIKoskaJBudoffMJ, et alFetuin-A does not explain ethnic disparity in cardiometabolic risk factors and subclinical atherosclerosis between Hispanics and non-Hispanic whites. Metab Syndr Relat Disord2011; 9(1): 77–79.
39.
HeissADuChesneADeneckeB, et alStructural basis of calcification inhibition by α2-HS glycoprotein/fetuin-A: Formation of colloidal calciprotein particles *. J Biol Chem2003; 278(15): 13333–13341.
40.
OsawaMTianWHoriuchiH, et alAssociation of α2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels. Hum Genet2005; 116(3): 146–151.
41.
RungrojNNettuwakulCSudtachatN, et alA whole genome SNP genotyping by DNA microarray and candidate gene association study for kidney stone disease. BMC Med Genet2014; 15: 50.
42.
ChenTQianBZouJ, et alOxalate as a potent promoter of kidney stone formation. Front Med2023; 10: 1159616.
43.
Samocha-BonetDTamCSCampbellLV, et alRaised circulating fetuin-a after 28-day overfeeding in healthy humans. Diabetes Care2014; 37(1): e15–e16.
44.
Öner-İyidoğanYSeyithanoğluMTanrıkulu-KüçükS, et alThe effect of dietary curcumin on hepatic chymase activity and serum fetuin-A levels in rats fed on a high-fat diet. J Food Biochem2017; 41(3): e12347.
45.
IcerMAYıldıranH.Effects of fetuin-A with diverse functions and multiple mechanisms on human health. Clin Biochem2021; 88: 1–10.
46.
SeyithanoğluMÖner-İyidoğanYDoğru-AbbasoğluS, et alThe effect of dietary curcumin and capsaicin on hepatic fetuin-A expression and fat accumulation in rats fed on a high-fat diet. Arch Physiol Biochem2016; 122(2): 94–102.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
